The oncology ecosystem is rapidly advancing with novel treatments and increased patient access, yet it faces significant challenges such as high costs, disparities in clinical trial representation and the need for equitable distribution of therapies. Emerging biopharma companies are leading the way in oncology innovation, while spending on cancer medicines is projected to rise significantly, stressing healthcare budgets despite the mitigating effects of biosimilars.
Digital health, particularly telehealth, remains a small yet growing component of oncology care, primarily used for ongoing cancer management, with usage patterns varying significantly by demographics and insurance type. As demand for virtual cancer care is expected to rise, understanding the quality and accessibility implications of these services is crucial for future healthcare delivery. Oncology saw advancements in early cancer diagnosis through AI, novel blood tests and improvements in patient care with updated screening recommendations and innovative treatments.
Immuno-oncology is also rapidly evolving, offering promising alternatives to traditional cancer treatments by harnessing the body’s immune system. Significant advancements have been made in checkpoint inhibitors, CAR-T cell therapies, ADCs and cancer vaccines. Emerging trends and innovative delivery systems are driving this progress, highlighting the potential for more effective and targeted cancer treatments.
Driven by these trends, the global oncology market size is poised to grow from $242.15 billion in 2024 to $521.60 billion by 2033, growing at a CAGR of 8.9 percent.
This edition of Healthcare Tech Outlook APAC brings insights into the latest developments in Oncology and how companies align with the latest trends to provide better healthcare outcomes for early cancer detection, diagnosis and improved patient care.
It features a thought leadership article from Rushir J. Choksi, M.D., Co-Chief Medical Officer of the Medical Oncology Network, UPMS Cancer Center who sheds light on the challenges and strategies in oncology for adopting new therapies, including the need for continuous adaptation to advancements, utilizing technology to manage and analyze patient data, setting and measuring quality initiatives and leveraging AI for proactive patient care. It also features an article from Emma Spellman, Associate Director Oncology, Diagnostics and Outpatients at The London Clinic, who delves into the need for continuous adaptation to technological advancements, patient-centric care, partnerships, cost management, compliance and data handling, while offering advice on leadership and professional development in the field.
In this edition featuring the Top Oncology Solutions Providers in APAC 2024, we hope you find the right partner to meet your organization's needs.
